Combined Chondroitin sulfate and Glucosamine is more efficient than Celebrex in reducing serum levels of COLL2-1, a cartilage degradation biomarker, in patients with severe OA: results from a randomized, double-blind, multicentric clinical trial
The objective of the study was to investigate soluble osteoarthritis (OA) biomarkers in the patients of the double-blind Multicentre Osteoarthritis interVEntion trial with Sysadoa (MOVES) comparing the symptomatic efficacy and safety of Chondroitin Sulfate (CS)+Glucosamine Hydrochloride (GH) versus...
Gespeichert in:
Veröffentlicht in: | Clinical therapeutics 2015-08, Vol.37 (8), p.e121-e122 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The objective of the study was to investigate soluble osteoarthritis (OA) biomarkers in the patients of the double-blind Multicentre Osteoarthritis interVEntion trial with Sysadoa (MOVES) comparing the symptomatic efficacy and safety of Chondroitin Sulfate (CS)+Glucosamine Hydrochloride (GH) versus CElecoxib (CE) in knee OA patients. |
---|---|
ISSN: | 0149-2918 1879-114X |
DOI: | 10.1016/j.clinthera.2015.05.347 |